Current recommendations for surgical management of early-stage breast cancer include breast-conserving surgery with postoperative irradiation. However, studies show that mastectomy is still being used by women with early-stage breast cancer.
Methods:
Review of the medical literature published between 2000 and 2010 to determine the factors associated with the decision of patients for surgical treatment in early-stage breast cancer.
Results:
The following patient characteristics affect the surgical decision-making process in early-stage breast cancer: age, socioeconomic factors, geographic area in which the patient lives, proximity to a radiation therapy center, testing for BRCA gene, breast imaging, and decision aids.
Conclusions:
Of increasing importance in the decision making about treatment of women with early-stage breast cancer are the woman's perception of having a surgical choice and the influence of that choice on postoperative quality of life.
Get full access to this article
View all access options for this article.
References
1.
Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. N Engl J Med, 1995; 333:1444–1455.Erratum in: N Engl J Med 1996;334:1003.
2.
VeronesiU, CascinelliN, MarianiLet al.Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med, 2002; 347:1227–1232.
3.
FisherB, JeongJH, AndersonS, BryantJ, FisherER, WolmarkN. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med, 2002; 347:567–575.
4.
NIH consensus conference. Treatment of early-stage breast cancer. JAMA, 1991; 265:391–395.
5.
GomezSL, LichtensztajnD, KurianAWet al.Increasing mastectomy rates for early-stage breast cancer? Population-based trends from California. J Clin Oncol, 2010; 28:e155–157.
6.
McGuireKP, SantillanAA, KaurPet al.Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol, 2009; 16:2682–2690.
7.
AdkissonCD, VallowLA, KowalchikKet al.Patient age and preoperative breast MRI in women with breast cancer: biopsy and surgical implications. Ann Surg Oncol, 2011; 18:1678–1683.
8.
DiabSG, ElledgeRM, ClarkGM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst, 2000; 92:550–556.
9.
HiotisK, YeW, SpostoR, SkinnerKA. Predictors of breast conservation therapy: size is not all that matters. Cancer, 2005; 103:892–899.
10.
PappoI, KarniT, SandbankJet al.Breast cancer in the elderly: histological, hormonal and surgical characteristics. Breast, 2007; 16:60–67.
11.
MartinMA, MeyrickeR, O'NeillT, RobertsS. Mastectomy or breast conserving surgery? Factors affecting type of surgical treatment for breast cancer: a classification tree approach. BMC Cancer, 2006; 6:98.
12.
StaradubVL, HsiehYC, ClausonJ, LangermanA, RademakerAW, MorrowM. Factors that influence surgical choices in women with breast carcinoma. Cancer, 2002; 95:1185–1190.
13.
WyldL, GargDK, KumarID, BrownH, ReedMW. Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines. Br J Cancer, 2004; 90:1486–1491.
14.
Ridao-LópezM, García-ArmestoS, Abadía-TairaB, Peiró-MorenoS, Bernal-DelgadoE. Income level and regional policies, underlying factors associated with unwarranted variations in conservative breast cancer surgery in Spain. BMC Cancer, 2011; 11:145.
15.
CaldonLJ, WaltersSJ, ReedJA, MurphyA, WorleyA, ReedMW. Case-mix fails to explain variation in mastectomy rates: management of screen-detected breast cancer in a UK region 1997–2003. Br J Cancer, 2005; 92:55–59.
16.
WhiteV, PrudenM, GilesGet al.The management of early breast carcinoma before and after the introduction of clinical practice guidelines. Cancer, 2004; 101:476–485.
17.
BradleyCJ, GivenCW, RobertsC. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst, 2002; 94:490–496.
18.
VotiL, RichardsonLC, ReisIM, FlemingLE, MackinnonJ, CoeberghJW. Treatment of local breast carcinoma in Florida: the role of the distance to radiation therapy facilities. Cancer, 2006; 106:201–207.
19.
KaplanCP, NapolesAM, HwangESet al.Selection of treatment among Latina and non-Latina white women with ductal carcinoma in situ. J Womens Health (Larchmt), 2011; 20:215–223.
20.
PrehnAW, TopolB, StewartS, GlaserSL, O'ConnorL, WestDW. Differences in treatment patterns for localized breast carcinoma among Asian/Pacific islander women. Cancer, 2002; 95:2268–2275.
21.
GomezSL, FranceAM, LeeMM. Socioeconomic status, immigration/acculturation, and ethnic variations in breast conserving surgery, San Francisco Bay area. Ethn Dis, 2004; 14,1:134–140.
22.
GoelMS, BurnsRB, PhillipsRS, DavisRB, Ngo-MetzgerQ, McCarthyEP. Trends in breast conserving surgery among Asian Americans and Pacific Islanders, 1992–2000. J Gen Intern Med, 2005; 20:604–611.
23.
McVeaKL, MinierWC, Johnson PalenskyJE. Low-income women with early-stage breast cancer: physician and patient decision-making styles. Psychooncology, 2001; 10:137–146.
24.
MorelandA, ZhangY, DissanaikeS, AryaR. Private insurance is the strongest predictor of women receiving breast conservation surgery for breast cancer. Am J Surg, 2009; 198:787–791.
25.
SchroenAT, BreninDR, KellyMD, KnausWA, SlingluffCL.Jr. Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. J Clin Oncol, 2005; 23:7074–7080.
26.
NattingerAB, KneuselRT, HoffmannRG, GilliganMA. Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst, 2001; 93:1344–1346.
27.
AthasWF, Adams-CameronM, HuntWC, Amir-FazliA, KeyCR. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst, 2000; 92:269–271.
28.
MaskarinecG, DhakalS, YamashiroG, IssellBF. The use of breast conserving surgery: linking insurance claims with tumor registry data. BMC Cancer, 2002; 2:3.
29.
GaudetteLA, GaoRN, SpenceA, ShiF, JohansenH, OlivottoIA. Declining use of mastectomy for invasive breast cancer in Canada, 1981–2000. Can J Public Health, 2004; 95:336–340.
30.
MastagliaB, KristjansonLJ. Factors influencing women's decisions for choice of surgery for Stage I and Stage II breast cancer in Western Australia. J Adv Nurs, 2001; 35:836–847.
31.
CelayaMO, ReesJR, GibsonJJ, RiddleBL, GreenbergER. Travel distance and season of diagnosis affect treatment choices for women with early-stage breast cancer in a predominantly rural population (United States)Cancer Causes Control, 2006; 17:851–856.
32.
MikiY, SwensenJ, Shattuck-EidensDet al.A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 1994; 266:66–71.
33.
RobsonM, SvahnT, McCormickBet al.Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series. Cancer, 2005; 103:44–51.
34.
JatoiI. Options in breast cancer local therapy: who gets what?World J Surg, 2012; 36:1498–1502.
35.
PierceLJ, PhillipsKA, GriffithKAet al.Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy. Breast Cancer Res Treat, 2010; 121:389–398.
36.
MislowskyA, DomchekS, StroedeCet al.Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: a retrospective cohort analysis of 158 mutation carriers treated at a single institution. Ann Surg Oncol, 2011; 18:745–751.
37.
YiM, HuntKK, ArunBKet al.Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prev Res (Phila), 2010; 3:1026–1034.
38.
MullanMH, WilkinsEG, GoldfarbSet al.Prospective analysis of psychosocial outcomes after breast reconstruction: cross-cultural comparisons of 1-year postoperative results. J Plast Reconstr Aesthet Surg, 2007; 60:503–508.
39.
ArringtonAK, JarosekSL, VirnigBA, HabermannEB, TuttleTM. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol, 2009; 16:2697–2704.
40.
NelsonJA, TchouJ, DomchekS, SonnadSS, SerlettiJM, WuLC. Breast reconstruction in bilateral prophylactic mastectomy patients: factors that influence decision making. J Plast Reconstr Aesthet Surg, 2012; 65:1481–1489.
41.
KatipamulaR, DegnimAC, HoskinTet al.Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol, 2009; 27:4082–4088.
42.
SorberoME, DickAW, BeckjordEB, AhrendtG. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol, 2009; 16:1597–1605.
43.
MorrowM, JagsiR, AldermanAKet al.Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA, 2009; 302:1551–1556.
44.
LamWW, FieldingR, HoEY, ChanM, OrA. Surgeon's recommendation, perceived operative efficacy and age dictate treatment choice by Chinese women facing breast cancer surgery. Psychooncology, 2005; 14:585–593.
45.
MandelblattJS, BergCD, MeropolNJet al.Measuring and predicting surgeons' practice styles for breast cancer treatment in older women. Med Care, 2001; 39:228–242.
46.
WeinbergE, WoodsS, GrannanK, HendyMP. The influence of gender of the surgeon on surgical procedure preference for breast cancer. Am Surg, 2002; 68:398–400.
47.
Jerome-D'EmiliaB, BegunJW. Diffusion of breast conserving surgery in medical communities. Soc Sci Med, 2005; 60:143–151.
48.
HawleyST, LantzPM, JanzNKet al.Factors associated with patient involvement in surgical treatment decision making for breast cancer. Patient Educ Couns, 2007; 65:387–395.
49.
MolenaarS, SprangersMA, RutgersEJet al.Decision support for patients with early-stage breast cancer: effects of an interactive breast cancer CDROM on treatment decision, satisfaction, and quality of life. J Clin Oncol, 2001; 19:1676–1687.
50.
WhelanT, LevineM, WillanAet al.Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial. JAMA, 2004; 292:435–441.
51.
PolskyD, KeatingNL, WeeksJC, SchulmanKA. Patient choice of breast cancer treatment: impact on health state preferences. Med Care, 2002; 40:1068–1079.
52.
HackTF, DegnerLF, WatsonP, SinhaL. Do patients benefit from participating in medical decision making? Longitudinal follow-up of women with breast cancer. Psycho-Oncology, 2006; 15:9–19.
53.
DeadmanJM, LeinsterSJ, OwensRG, DeweyME, SladePD. Taking responsibility for cancer treatment. Soc Sci Med, 2001; 53:669–677.
54.
ChangJT, ChenCJ, LinYC, ChenYC, LinCY, ChengAJ. Health-related quality of life and patient satisfaction after treatment for breast cancer in northern Taiwan. Int J Radiat Oncol Biol Phys, 2007; 69:49–53.
55.
KeatingNL, GuadagnoliE, LandrumMB, BorbasC, WeeksJC. Treatment decision making in early-stage breast cancer: should surgeons match patients' desired level of involvement?J Clin Oncol, 2002; 20:1473–1479.
56.
JanzNK, WrenPA, CopelandLA, LoweryJC, GoldfarbSL, WilkinsEG. Patient-physician concordance: preferences, perceptions, and factors influencing the breast cancer surgical decision. J Clin Oncol, 2004; 22:3091–3098.
57.
LantzPM, JanzNK, FagerlinAet al.Satisfaction with surgery outcomes and the decision process in a population-based sample of women with breast cancer. Health Serv Res, 2005; 40:745–767.
58.
KatzSJ, LantzPM, ZemencukJK. Correlates of surgical treatment type for women with noninvasive and invasive breast cancer. J Womens Health Gend Based Med, 2001; 10:659–670.
59.
KatzSJ, LantzPM, JanzNKet al.Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol, 2005; 23:5526–5533.
60.
CollinsED, MooreCP, ClayKFet al.Can women with early-stage breast cancer make an informed decision for mastectomy?J Clin Oncol, 2009; 27:519–525.
